- •
Low-dose aspirin (LDA) (80–160 mg) reduces the risk of preeclampsia (PE) and intrauterine growth restriction by approximately half when started in early pregnancy.
- •
LDA reduces mainly the preterm and severe forms of PE when started in early pregnancy.
- •
Women with chronic hypertension and those with prior PE should begin taking LDA in early pregnancy.
- •
First-trimester screening programs should be implemented to identify women at high-risk for preterm or severe PE.
- •
Further studies should evaluate the
Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction
Section snippets
Key points
Summary
Studies have demonstrated that LDA administered in early gestation is efficient in reducing the risk of PE, IUGR, preterm birth, and perinatal death in high-risk women, especially those at high risk for deep placentation disorders, preterm PE, and severe IUGR. First-trimester screening programs for such adverse pregnancy outcomes are increasingly promising, and recent studies combining a first-trimester screening strategy with prophylactic LDA demonstrated a significant decrease of early onset
References (77)
Pre-eclampsia
Lancet
(2000)- et al.
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
Am J Obstet Gynecol
(2011) - et al.
Pre-eclampsia
Lancet
(2010) - et al.
Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy
Placenta
(1980) - et al.
The human placental bed: electron microscopic study of trophoblastic invasion of spiral arteries
Am J Obstet Gynecol
(1980) - et al.
Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT
J Thromb Haemost
(2012) - et al.
Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis
J Obstet Gynaecol Can
(2009) - et al.
The frequency and severity of placental findings in women with preeclampsia are gestational age dependent
Am J Obstet Gynecol
(2003) - et al.
Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes
Am J Obstet Gynecol
(2003) - et al.
Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes
Am J Obstet Gynecol
(2002)
Aspirin for the treatment of recurrent toxaemia
Lancet
Effect of aspirin on incidence of pre-eclampsia
Lancet
Prevention of pre-eclampsia by early antiplatelet therapy
Lancet
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Lancet
Association between first-trimester placental volume and birth weight
Placenta
Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women
Am J Obstet Gynecol
Validation of metabolomic models for prediction of early-onset preeclampsia
Am J Obstet Gynecol
Competing risks model in screening for preeclampsia by maternal characteristics and medical history
Am J Obstet Gynecol
Low-dose ASA response using the PFA-100 in women with high-risk pregnancy
J Obstet Gynaecol Can
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial
Lancet
Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial
Blood
A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia
Eur J Obstet Gynecol Reprod Biol
Low-dose aspirin and hypertension in pregnancy
Lancet
Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches
BJOG
Report of the national high blood pressure education program working group on high blood pressure in pregnancy
Am J Obstet Gynecol
Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of hypertensive disorders of pregnancy
Am J Obstet Gynecol
Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia
J Perinat Med
Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin
J Matern Fetal Neonatal Med
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary
J Obstet Gynaecol Can
Calcium supplementation and prevention of preeclampsia: a meta-analysis
J Matern Fetal Neonatal Med
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis
Obstet Gynecol
Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis
Am J Perinatol
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis
Fetal Diagn Ther
Antioxidants for preventing pre-eclampsia
Cochrane Database Syst Rev
Progesterone for preventing pre-eclampsia and its complications
Cochrane Database Syst Rev
Exercise or other physical activity for preventing pre-eclampsia and its complications
Cochrane Database Syst Rev
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis
Ultrasound Obstet Gynecol
Diagnosis and management of preeclampsia and eclampsia
Int J Gynaecol Obstet
Cited by (0)
Disclosure: None of the authors have a conflict of interest.